Literature DB >> 21153684

Characterizing the novel protein p33MONOX.

Manisha Mishra1, Noriko Inoue, Klaus Heese.   

Abstract

The novel protein p33MONOX (p33Monooxygenase) was over-expressed in neuroblastoma cells demonstrating its inhibitory effect on the phosphorylation of the App (amyloid precursor protein) and Bcl2 (B-cell lymphoma 2) proteins but mediating higher activation of Mapk1/3 (mitogen-activated protein kinase 1/3). We employed a variety of cell biology techniques to show the localization of p33MONOX to the cytoplasm of pyramidal neurons in the mouse brain hippocampus. We also carried out a yeast-two-hybrid screening plus co-immunoprecipitation and bio-informatics to determine COBRA1 (cofactor of BRCA1 (breast cancer type 1)), NOL12 (nucleolar protein 12), and PRNP (prion protein) as p33MONOX-interacting proteins. Bio-computational analyses revealed a flavine-containing monooxygenase (FMO)-1 motif, thus linking p33MONOX to a group of previously characterized proteins, the MICALs (molecule interacting with CasL). Concluding, p33MONOX might regulate pre- and post-transcriptional control of dynamic processes related to growth cone guidance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21153684     DOI: 10.1007/s11010-010-0690-4

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  52 in total

1.  Mono- and multisite phosphorylation enhances Bcl2's antiapoptotic function and inhibition of cell cycle entry functions.

Authors:  Xingming Deng; Fengqin Gao; Tammy Flagg; W Stratford May
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-05       Impact factor: 11.205

2.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

3.  Identification and characterisation of the novel amyloid-beta peptide-induced protein p17.

Authors:  Saheen Nehar; Manisha Mishra; Klaus Heese
Journal:  FEBS Lett       Date:  2009-09-13       Impact factor: 4.124

4.  Selective neuronal vulnerability and inadequate stress response in superoxide dismutase mutant mice.

Authors:  Stephen Lynn; Eric J Huang; Sailaja Elchuri; Mohammed Naeemuddin; Yumiko Nishinaka; Junji Yodoi; Donna M Ferriero; Charles J Epstein; Ting-Ting Huang
Journal:  Free Radic Biol Med       Date:  2005-03-15       Impact factor: 7.376

5.  Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease.

Authors:  K A Welsh; N Butters; J P Hughes; R C Mohs; A Heyman
Journal:  Arch Neurol       Date:  1992-05

Review 6.  Introduction: flavoprotein structure and mechanism.

Authors:  V Massey
Journal:  FASEB J       Date:  1995-04       Impact factor: 5.191

7.  Immunoquantitation of FMO1 in human liver, kidney, and intestine.

Authors:  C K Yeung; D H Lang; K E Thummel; A E Rettie
Journal:  Drug Metab Dispos       Date:  2000-09       Impact factor: 3.922

8.  Novel gene expressed in nasal region influences outgrowth of olfactory axons and migration of luteinizing hormone-releasing hormone (LHRH) neurons.

Authors:  P R Kramer; S Wray
Journal:  Genes Dev       Date:  2000-07-15       Impact factor: 11.361

9.  Nasal embryonic LHRH factor (NELF) expression within the CNS and PNS of the rodent.

Authors:  P R Kramer; S Wray
Journal:  Brain Res Gene Expr Patterns       Date:  2001-08

10.  APP processing is regulated by cytoplasmic phosphorylation.

Authors:  Ming-Sum Lee; Shih-Chu Kao; Cynthia A Lemere; Weiming Xia; Huang-Chun Tseng; Ying Zhou; Rachael Neve; Michael K Ahlijanian; Li-Huei Tsai
Journal:  J Cell Biol       Date:  2003-10-13       Impact factor: 10.539

View more
  1 in total

1.  The protein p17 signaling pathways in cancer.

Authors:  Klaus Heese
Journal:  Tumour Biol       Date:  2013-07-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.